Smartleaf Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.72M Buy
40,005
+3,113
+8% +$359K 0.17% 108
2025
Q4
$3.91M Buy
36,892
+4,135
+13% +$388K 0.15% 125
2025
Q3
$2.57M Buy
32,757
+5,893
+22% +$485K 0.16% 139
2025
Q2
$2.13M Sell
26,864
-7,084
-21% -$563K 0.19% 108
2025
Q1
$3.03M Sell
33,948
-1,977
-6% -$185K 0.29% 68
2024
Q4
$3.53M Buy
35,925
+2,058
+6% +$212K 0.36% 50
2024
Q3
$3.85M Buy
33,867
+5,625
+20% +$668K 0.47% 40
2024
Q2
$3.67M Buy
28,242
+3,696
+15% +$476K 0.6% 31
2024
Q1
$3.23M Buy
24,546
+5,136
+26% +$633K 0.63% 35
2023
Q4
$2.12M Buy
+19,410
New +$2.01M 0.57% 40

Other funds holding MRK

Smartleaf Asset Management's MRK Position: Q1 2026 in Review

Smartleaf Asset Management increased its Merck (MRK) stake by 8.4% in Q1 2026, buying an estimated $359K and bringing the position to 40,005 shares worth $4.72M. The position accounts for 0.17% of the portfolio, ranked #108.

Smartleaf Asset Management first reported a position in MRK in Q4 2023 and has held it in 10 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Smartleaf Asset Management held 40,005 shares of Merck worth $4.72M as of Q1 2026.
  • Smartleaf Asset Management bought 3,113 Merck shares in Q1 2026, an estimated $359K.
  • Merck made up 0.17% of Smartleaf Asset Management's portfolio in Q1 2026, its #108 holding.
  • Smartleaf Asset Management first reported a position in Merck in Q4 2023 and has held it in 10 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.